Xiumin Wu

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells

Farbod Shojaei, Xiumin Wu, Ajay K. Malik et al. · Nature Biotechnology · 2007 · 837 citations

Hematological Malignancy, Oncology, Medicine +10

Therapeutic antibody targeting of individual Notch receptors

Yan Wu, Carol Cain-Hom, Lisa Choy et al. · Nature · 2010 · 710 citations · Full text

Immunology, Receptor (Biochemistry), Immunochemistry +5

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

Farbod Shojaei, Xiumin Wu, Cuiling Zhong et al. · Nature · 2007 · 636 citations

Myeloid-cell-dependent Tumour Angiogenesis, Malignant Blood Disorder, Myelopoiesis +4

PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment

Yongping Crawford, Ian Kasman, Lanlan Yu et al. · Cancer Cell · 2009 · 605 citations · Full text

Tumors Refractory, Angiogenesis, Pathology +11

Tumour‐secreted miR‐9 promotes endothelial cell migration and angiogenesis by activating the JAK‐STAT pathway

Guanglei Zhuang, Xiumin Wu, Zhaoshi Jiang et al. · The EMBO Journal · 2012 · 469 citations · Full text